By Puyaan Singh and Leroy Leo (Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday recommended for the approval of Guardant Health's blood test to detect a cancer that begins in the colon or rectum. The panel voted seven-to-two in ...